0 XP   0   0   0

Catalyst Biosciences Inc
Buy or Sell?

I guess you are interested in Catalyst Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Catalyst Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Catalyst Biosciences Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Catalyst Biosciences Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Catalyst Biosciences Inc. The closing price on 2022-09-23 was $0.4894 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of Catalyst Biosciences Inc
Catalyst Biosciences Inc Daily Candlestick Chart

1.1. Profitability of Catalyst Biosciences Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Catalyst Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-940.4%+940.4%
TTM-940.4%YOY-1,504.1%+563.7%
TTM-940.4%5Y-19,357.9%+18,417.4%
5Y-19,357.9%10Y-12,851.4%-6,506.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM-940.4%-275.9%-664.5%
YOY-1,504.1%-328.0%-1,176.1%
5Y-19,357.9%-464.6%-18,893.3%
10Y-12,851.4%-547.1%-12,304.3%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of Catalyst Biosciences Inc:

  • The MRQ is 61.9%. Very good. +2
  • The TTM is -10.7%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ61.9%TTM-10.7%+72.6%
TTM-10.7%YOY-18.2%+7.5%
TTM-10.7%5Y-12.1%+1.4%
5Y-12.1%10Y-9.9%-2.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ61.9%-9.8%+71.7%
TTM-10.7%-8.8%-1.9%
YOY-18.2%-9.2%-9.0%
5Y-12.1%-11.6%-0.5%
10Y-9.9%-12.7%+2.8%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of Catalyst Biosciences Inc:

  • The MRQ is 65.3%. Very good. +2
  • The TTM is -19.8%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ65.3%TTM-19.8%+85.2%
TTM-19.8%YOY-21.7%+1.9%
TTM-19.8%5Y-15.8%-4.0%
5Y-15.8%10Y-14.0%-1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ65.3%-11.9%+77.2%
TTM-19.8%-11.2%-8.6%
YOY-21.7%-10.6%-11.1%
5Y-15.8%-13.7%-2.1%
10Y-14.0%-14.5%+0.5%

1.2. Operating Efficiency of Catalyst Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Catalyst Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-940.2%+940.2%
TTM-940.2%YOY-1,505.9%+565.8%
TTM-940.2%5Y-21,958.0%+21,017.8%
5Y-21,958.0%10Y-14,107.4%-7,850.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM-940.2%-269.6%-670.6%
YOY-1,505.9%-306.8%-1,199.1%
5Y-21,958.0%-461.8%-21,496.2%
10Y-14,107.4%-546.8%-13,560.6%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Catalyst Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.204-10.204
TTM10.204YOY16.048-5.845
TTM10.2045Y354.608-344.404
5Y354.60810Y220.217+134.391
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM10.2043.662+6.542
YOY16.0483.692+12.356
5Y354.6085.743+348.865
10Y220.2176.919+213.298

1.3. Liquidity of Catalyst Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Catalyst Biosciences Inc:

  • The MRQ is 18.861. Very Good. +2
  • The TTM is 7.391. Very Good. +2
Trends
Current periodCompared to+/- 
MRQ18.861TTM7.391+11.469
TTM7.391YOY6.471+0.920
TTM7.3915Y15.430-8.038
5Y15.43010Y14.341+1.088
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.8615.318+13.543
TTM7.3916.219+1.172
YOY6.4716.366+0.105
5Y15.4306.760+8.670
10Y14.3416.520+7.821
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Catalyst Biosciences Inc:

  • The MRQ is 1.160. Tight, but oke.
  • The TTM is 2.893. Very good. +2
Trends
Current periodCompared to+/- 
MRQ1.160TTM2.893-1.733
TTM2.893YOY8.515-5.622
TTM2.8935Y21.554-18.661
5Y21.55410Y19.738+1.815
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1604.101-2.941
TTM2.8934.994-2.101
YOY8.5155.256+3.259
5Y21.5545.338+16.216
10Y19.7385.050+14.688

1.4. Solvency of Catalyst Biosciences Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of Catalyst Biosciences Inc:

  • The MRQ is 0.052. Very good. +2
  • The TTM is 0.217. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.052TTM0.217-0.165
TTM0.217YOY0.161+0.055
TTM0.2175Y0.145+0.072
5Y0.14510Y0.192-0.047
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0520.269-0.217
TTM0.2170.267-0.050
YOY0.1610.297-0.136
5Y0.1450.362-0.217
10Y0.1920.398-0.206
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of Catalyst Biosciences Inc:

  • The MRQ is 0.055. Very good. +2
  • The TTM is 0.297. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.055TTM0.297-0.243
TTM0.297YOY0.194+0.104
TTM0.2975Y0.186+0.111
5Y0.18610Y0.343-0.157
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0550.305-0.250
TTM0.2970.303-0.006
YOY0.1940.309-0.115
5Y0.1860.382-0.196
10Y0.3430.436-0.093

2. Market Valuation of Catalyst Biosciences Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Catalyst Biosciences Inc:

  • The EOD is -1.787. Company is losing money. -2
  • The MRQ is -6.498. Company is losing money. -2
  • The TTM is -2.102. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.787MRQ-6.498+4.712
MRQ-6.498TTM-2.102-4.397
TTM-2.102YOY-1.666-0.435
TTM-2.1025Y-2.168+0.067
5Y-2.16810Y-1.167-1.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.787-2.088+0.301
MRQ-6.498-2.275-4.223
TTM-2.102-3.793+1.691
YOY-1.666-4.994+3.328
5Y-2.168-3.642+1.474
10Y-1.167-3.303+2.136
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of Catalyst Biosciences Inc:

  • The MRQ is 0.071. Very good. +2
  • The TTM is -0.073. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ0.071TTM-0.073+0.145
TTM-0.073YOY0.242-0.315
TTM-0.0735Y0.016-0.089
5Y0.01610Y0.009+0.007
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0710.005+0.066
TTM-0.0730.020-0.093
YOY0.2420.041+0.201
5Y0.0160.021-0.005
10Y0.0090.017-0.008

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Catalyst Biosciences Inc:

  • The EOD is 0.195. Very good. +2
  • The MRQ is 0.709. Very good. +2
  • The TTM is 1.074. Good. +1
Trends
Current periodCompared to+/- 
EOD0.195MRQ0.709-0.514
MRQ0.709TTM1.074-0.366
TTM1.074YOY1.452-0.378
TTM1.0745Y1.252-0.178
5Y1.25210Y0.667+0.586
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.1951.808-1.613
MRQ0.7091.944-1.235
TTM1.0742.750-1.676
YOY1.4523.490-2.038
5Y1.2522.731-1.479
10Y0.6672.401-1.734

2.4. Latest News of Catalyst Biosciences Inc

Does Catalyst Biosciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Catalyst Biosciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-19
15:43
Bullish insiders at Catalyst Biosciences, Inc. (NASDAQ:CBIO) loaded up on US$1.2m of stock earlier this yearRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Catalyst Biosciences Inc.

3.1. Institutions holding Catalyst Biosciences Inc

Institutions are holding 25.948% of the shares of Catalyst Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31Nantahala Capital Management, LLC7.69060.07072420789-340871-12.343
2022-03-31Vanguard Group Inc4.42710139351200
2022-03-31Sabby Management LLC4.19350.1301132000018166615.9589
2022-03-31Renaissance Technologies Corp3.71660.00091169862-602046-33.9773
2022-06-30Madison Avenue Partners, LP3.19690.3664100630010063000
2022-03-31Millennium Management LLC2.02620.0002637799-271439-29.8535
2022-03-31Ikarian Capital, LLC1.51420.0413476625222794.9035
2022-03-31Geode Capital Management, LLC0.95050299201126164.4022
2022-03-31Bank of New York Mellon Corp0.68880216807141498187.8899
2022-03-31RBF LLC0.42060.005613239600
2022-03-31Goldman Sachs Group Inc0.37270117312-123299-51.2441
2022-06-30Kynam Capital Management, LP0.29680.042493434-12655-11.9287
2022-03-31Css LLC0.28170.00218865600
2022-03-31Northern Trust Corp0.2659083688-18468-18.0782
2022-03-31Essex Woodlands Health Ventures0.24980.01267862200
2022-03-31Dimensional Fund Advisors, Inc.0.245077127-415574-84.3461
2022-03-31State Street Corporation0.230607259900
2022-06-30Johnson & Johnson0.21270.03046695100
2022-03-31Two Sigma Investments LLC0.19930.000162729-245823-79.6699
2022-03-31Morgan Stanley - Brokerage Accounts0.1993062725-451503-87.8021
Total 31.37880.70289877134  

3.2. Funds holding Catalyst Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Vanguard Total Stock Mkt Idx Inv2.62570.000182650200
2022-07-31Vanguard Extended Market Index Investor1.63050.00151324300
2022-06-30Fidelity® Extended Market Index0.52710.00116592000
2022-06-30BlackRock Extended Mkt Composite0.34330.00161080481080480
2022-06-30BlackRock Extended Equity Market K0.30590.0016962781760.1831
2022-06-30Fidelity® Total Market Index0.11330.00013566700
2022-06-30Fidelity® Series Total Market Index0.10960.00013450700
2022-06-30NT Ext Equity Mkt Idx Fd - NL0.09430.00112967100
2022-06-30Fidelity® NASDAQ Composite Index®0.07980.00052512400
2022-07-31Vanguard Balanced Index Inv0.07620.00012397500
2022-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0750.00112360615136.8483
2022-06-30NT Ext Equity Mkt Idx Fd - L0.07340.0012309000
2022-06-30Northern Trust Extended Eq Market Idx0.07340.0012309000
2022-06-30BlackRock U.S. Equity Market F0.06790.0003213791770.8348
2022-06-30Spartan Total Market Index Pool E0.03720.000111702245826.5902
2022-06-30NT Quality Small Cap Core0.03570.007411239-203-1.7742
2022-06-30NT Quality SCC US Fund - L0.03570.007211239-203-1.7742
2022-07-31Vanguard U.S. Eq Idx £ Acc0.02950.0001929200
2022-07-29iShares Core S&P Total US Stock Mkt ETF0.02570809500
2022-07-31State St US Extended Mkt Indx NL Cl C0.02350.0005740500
Total 6.38270.02592009072  

3.3. Insider Transactions

Insiders are holding 23.022% of the shares of Catalyst Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2020-03-16Howard LevyBUY25004.052500
2020-03-13John P RichardBUY25003.983716
2020-03-13Nassim UsmanBUY40003.9111010
2020-03-13Veronica CaiBUY20004.117353
2020-03-04Eddie WilliamsBUY20006.03 
2019-05-24John P RichardBUY10008.031216
2018-11-16Howard LevySELL173117733
2018-03-08James E FlynnSELL7177830.53
2018-03-06James E FlynnSELL5246130.87
2015-12-17Fletcher PayneBUY100002
2015-12-17Stephen A HillBUY50002.0320711
2015-12-17Nassim UsmanBUY40002
2013-12-05Scott SandellSELL10005.13
2013-11-21M James BarrettSELL53335.16
2013-05-10Julia R BrownBUY60005.09
2013-03-11Stephen A HillBUY200004.43
2012-11-16Bvf Partners L P/IlBUY5950004
2012-11-08Bvf Partners L P/IlBUY724294.03
2012-11-02Bvf Partners L P/IlBUY1397004.05

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Catalyst Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--2.5121.654+52%3.523-29%5.950-58%137.757-98%
Current Ratio--18.8617.391+155%6.471+191%15.430+22%14.341+32%
Debt To Asset Ratio--0.0520.217-76%0.161-68%0.145-64%0.192-73%
Debt To Equity Ratio--0.0550.297-82%0.194-72%0.186-71%0.343-84%
Eps--1.640-0.068+104%-0.752+146%-0.678+141%-10.249+725%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----9.4040%-15.0410%-193.5790%-128.5140%
Operating Margin----9.4020%-15.0590%-219.5800%-141.0740%
Operating Ratio---10.204-100%16.048-100%354.608-100%220.217-100%
Pb Ratio0.195-264%0.7091.074-34%1.452-51%1.252-43%0.667+6%
Pe Ratio-1.787+73%-6.498-2.102-68%-1.666-74%-2.168-67%-1.167-82%
Peg Ratio--0.071-0.073+202%0.242-70%0.016+348%0.009+671%
Price Per Share0.489-264%1.7801.866-5%4.995-64%6.986-75%5.353-67%
Quick Ratio--1.1602.893-60%8.515-86%21.554-95%19.738-94%
Return On Assets--0.619-0.107+117%-0.182+129%-0.121+120%-0.099+116%
Return On Equity--0.653-0.198+130%-0.217+133%-0.158+124%-0.140+121%
 EOD+2 -1MRQTTM+11 -2YOY+11 -25Y+10 -310Y+9 -4

4.2. Fundamental Score

Let's check the fundamental score of Catalyst Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.787
Price to Book Ratio (EOD)Between0-10.195
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.160
Current Ratio (MRQ)Greater than118.861
Debt To Asset Ratio (MRQ)Less than10.052
Debt to Equity Ratio (MRQ)Less than10.055
Return On Equity (MRQ)Greater than0.150.653
Return on Assets (MRQ)Greater than0.050.619
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Catalyst Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than509.156
Ma 20Greater thanMa 501.729
Ma 50Greater thanMa 1001.797
Ma 100Greater thanMa 2001.489
OpenGreater thanClose0.540
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Income before Tax  -19,928-5,310-25,2384,909-20,3295,793-14,53666,16851,632
Net Income  -19,928-5,310-25,2384,909-20,3295,793-14,53666,16851,632
Net Income from Continuing Operations  -19,928-5,310-25,2384,909-20,3295,793-14,53666,16851,632
Net Income Applicable to Common Shares  -19,928-5,310-25,2384,909-20,3295,793-14,53666,16851,632



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets83,373
Total Liabilities4,311
Total Stockholder Equity79,062
 As reported
Total Liabilities 4,311
Total Stockholder Equity+ 79,062
Total Assets = 83,373

Assets

Total Assets83,373
Total Current Assets81,308
Long-term Assets81,308
Total Current Assets
Cash And Cash Equivalents 75,394
Net Receivables 5,000
Total Current Assets  (as reported)81,308
Total Current Assets  (calculated)80,394
+/- 914
Long-term Assets
Property Plant Equipment 1,897
Other Assets 168
Long-term Assets  (as reported)2,065
Long-term Assets  (calculated)2,065
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,311
Long-term Liabilities0
Total Stockholder Equity79,062
Total Current Liabilities
Accounts payable 1,037
Total Current Liabilities  (as reported)4,311
Total Current Liabilities  (calculated)1,037
+/- 3,274
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock31
Total Stockholder Equity (as reported)79,062
Total Stockholder Equity (calculated)31
+/- 79,031
Other
Capital Stock31
Common Stock Shares Outstanding 31,477
Net Invested Capital 79,062
Net Tangible Assets 79,062
Net Working Capital 76,997



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-31
> Total Assets 
0
0
0
28,001
31,558
68,523
63,941
81,368
73,911
69,912
97,709
98,965
121,687
114,305
105,855
98,551
91,370
82,049
83,920
319,379
293,107
292,783
278,259
262,787
239,555
300,018
279,739
258,126
231,104
212,622
203,499
189,579
178,745
167,486
157,847
145,873
134,108
124,515
116,121
111,999
107,136
101,174
74,513
69,521
61,543
57,219
51,616
38,090
29,060
39,630
34,393
39,513
145,886
139,542
133,416
124,920
111,870
100,873
91,792
98,554
110,563
123,684
111,804
94,846
119,076
101,786
78,537
55,662
40,274
83,373
83,37340,27455,66278,537101,786119,07694,846111,804123,684110,56398,55491,792100,873111,870124,920133,416139,542145,88639,51334,39339,63029,06038,09051,61657,21961,54369,52174,513101,174107,136111,999116,121124,515134,108145,873157,847167,486178,745189,579203,499212,622231,104258,126279,739300,018239,555262,787278,259292,783293,107319,37983,92082,04991,37098,551105,855114,305121,68798,96597,70969,91273,91181,36863,94168,52331,55828,001000
   > Total Current Assets 
0
0
0
25,741
29,308
65,875
61,351
78,853
71,108
66,755
93,888
92,413
97,527
106,831
98,671
91,966
85,182
76,289
78,574
314,429
287,436
244,608
233,029
218,079
200,324
237,025
216,814
198,693
179,344
159,168
148,097
127,743
111,627
102,521
98,590
93,606
98,479
98,747
98,989
108,141
105,236
100,191
72,854
68,698
60,736
56,291
50,775
37,521
28,536
39,272
34,078
39,109
145,433
138,977
132,809
123,991
109,002
98,057
89,138
96,066
108,275
121,345
107,972
89,510
116,520
96,826
73,964
51,476
36,703
81,308
81,30836,70351,47673,96496,826116,52089,510107,972121,345108,27596,06689,13898,057109,002123,991132,809138,977145,43339,10934,07839,27228,53637,52150,77556,29160,73668,69872,854100,191105,236108,14198,98998,74798,47993,60698,590102,521111,627127,743148,097159,168179,344198,693216,814237,025200,324218,079233,029244,608287,436314,42978,57476,28985,18291,96698,671106,83197,52792,41393,88866,75571,10878,85361,35165,87529,30825,741000
       Cash And Cash Equivalents 
0
0
0
24,851
27,200
51,377
46,514
41,744
55,180
42,585
51,871
53,403
65,467
64,366
61,502
51,202
43,005
45,919
48,229
83,909
241,950
221,626
185,799
165,854
138,837
168,142
130,541
107,283
88,668
71,645
78,202
82,240
69,861
63,059
61,739
54,485
45,041
43,417
45,707
56,430
73,113
78,198
23,096
29,096
20,580
11,333
9,317
10,264
14,533
32,388
10,973
14,472
126,550
46,533
35,998
31,213
25,024
17,348
23,018
15,369
70,364
59,273
24,923
30,360
83,044
73,621
59,157
44,347
34,817
75,394
75,39434,81744,34759,15773,62183,04430,36024,92359,27370,36415,36923,01817,34825,02431,21335,99846,533126,55014,47210,97332,38814,53310,2649,31711,33320,58029,09623,09678,19873,11356,43045,70743,41745,04154,48561,73963,05969,86182,24078,20271,64588,668107,283130,541168,142138,837165,854185,799221,626241,95083,90948,22945,91943,00551,20261,50264,36665,46753,40351,87142,58555,18041,74446,51451,37727,20024,851000
       Short-term Investments 
0
0
0
0
0
12,111
12,271
12,445
12,606
20,412
38,485
33,637
28,784
37,555
32,246
37,161
37,233
27,193
27,082
27,157
43,140
19,450
42,182
48,168
58,481
65,041
82,939
87,721
87,890
84,833
65,498
42,721
39,978
37,138
35,017
37,844
52,204
54,298
52,209
50,955
31,646
21,576
13,665
3,402
7,087
12,617
10,208
6,800
6,800
5,997
16,477
17,971
16,968
89,613
93,223
88,914
80,253
76,587
61,932
61,496
34,164
58,091
77,959
48,994
23,956
12,902
5,371
2,504
0
0
002,5045,37112,90223,95648,99477,95958,09134,16461,49661,93276,58780,25388,91493,22389,61316,96817,97116,4775,9976,8006,80010,20812,6177,0873,40213,66521,57631,64650,95552,20954,29852,20437,84435,01737,13839,97842,72165,49884,83387,89087,72182,93965,04158,48148,16842,18219,45043,14027,15727,08227,19337,23337,16132,24637,55528,78433,63738,48520,41212,60612,44512,27112,11100000
       Net Receivables 
0
0
0
118
816
1,263
1,180
23,368
2,083
2,243
2,367
4,197
1,802
2,841
2,845
2,073
3,650
1,687
1,761
201,801
846
557
1,743
838
527
546
625
218
319
347
2,548
1,380
383
108
32
278
343
28
57
141
68
10
648
492
448
462
101
31
227
135
52
24
24
0
0
10
0
0
0
15,000
1,366
1,988
1,555
3,313
1,006
1,971
1,114
1,818
564
5,000
5,0005641,8181,1141,9711,0063,3131,5551,9881,36615,00000010002424521352273110146244849264810681415728343278321083831,3802,5483473192186255465278381,743557846201,8011,7611,6873,6502,0732,8452,8411,8024,1972,3672,2432,08323,3681,1801,263816118000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,842
3,334
3,689
2,786
2,690
4,397
2,782
1,788
2,324
1,802
999
891
1,004
1,016
615
409
407
620
1,914
1,633
1,484
1,430
958
1,041
6,749
6,576
6,642
1,915
2,831
3,588
3,864
3,725
4,122
4,188
4,201
2,381
1,993
3,535
6,843
8,514
8,332
8,322
2,807
1,322
0
01,3222,8078,3228,3328,5146,8433,5351,9932,3814,2014,1884,1223,7253,8643,5882,8311,9156,6426,5766,7491,0419581,4301,4841,6331,9146204074096151,0161,0048919991,8022,3241,7882,7824,3972,6902,7863,6893,3343,8420000000000000000000000000
   > Long-term Assets 
0
0
0
2,260
2,250
2,647
2,590
2,516
2,803
3,156
3,821
6,552
24,160
7,475
7,184
6,585
6,188
5,760
5,346
4,950
5,671
48,175
45,230
44,708
39,231
62,993
62,925
59,433
51,760
53,454
55,402
61,836
67,118
64,965
59,257
52,267
35,629
25,768
17,132
3,858
1,900
983
1,659
823
807
928
841
569
524
358
315
404
453
565
607
929
2,868
2,816
2,654
2,488
2,288
2,339
3,832
5,336
2,556
4,960
4,573
4,186
3,571
2,065
2,0653,5714,1864,5734,9602,5565,3363,8322,3392,2882,4882,6542,8162,8689296075654534043153585245698419288078231,6599831,9003,85817,13225,76835,62952,26759,25764,96567,11861,83655,40253,45451,76059,43362,92562,99339,23144,70845,23048,1755,6714,9505,3465,7606,1886,5857,1847,47524,1606,5523,8213,1562,8032,5162,5902,6472,2502,260000
       Property Plant Equipment 
0
0
0
1,748
1,746
2,153
2,105
2,040
2,337
2,700
3,374
6,115
7,279
7,056
6,775
6,401
6,008
5,584
5,175
4,783
5,508
5,367
5,037
6,072
6,074
5,857
5,409
5,035
4,453
3,919
3,375
1,639
1,501
944
748
682
611
541
483
428
373
149
709
698
682
803
716
444
399
358
315
276
325
291
255
386
356
371
339
304
296
481
1,963
2,265
2,028
3,791
3,704
3,714
3,099
1,897
1,8973,0993,7143,7043,7912,0282,2651,9634812963043393713563862552913252763153583994447168036826987091493734284835416116827489441,5011,6393,3753,9194,4535,0355,4095,8576,0746,0725,0375,3675,5084,7835,1755,5846,0086,4016,7757,0567,2796,1153,3742,7002,3372,0402,1052,1531,7461,748000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,995
57,380
54,266
47,179
49,412
51,908
59,966
65,220
63,810
58,355
51,448
34,898
25,120
16,630
3,418
1,518
828
825
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,171
2,543
0
0
0
0
0
0
0000002,5431,17100000000000000000008258281,5183,41816,63025,12034,89851,44858,35563,81065,22059,96651,90849,41247,17954,26657,38056,9950000000000000000000000000
       Intangible Assets 
0
0
0
513
504
494
485
475
466
456
447
437
428
419
409
184
180
176
171
167
163
158
154
149
145
141
136
132
132
123
119
115
110
106
102
97
93
89
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000899397102106110115119123132132136141145149154158163167171176180184409419428437447456466475485494504513000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
116
287
105
52
40
27
18
19
12
9
6
950
125
125
125
125
125
125
0
0
128
128
274
352
543
197
257
257
257
197
198
698
4,903
528
1,169
869
472
472
168
1684724728691,1695284,90369819819725725725719754335227412812800125125125125125125950691219182740521052871160000000000000000000000000000000
> Total Liabilities 
0
0
0
190,482
201,927
16,131
16,117
16,370
13,405
15,946
39,148
47,381
46,466
45,021
43,598
41,178
38,058
37,813
37,080
250,388
214,869
206,756
187,895
170,940
131,992
110,919
97,727
83,838
52,402
16,259
12,929
13,664
9,290
9,305
11,114
11,262
10,007
7,497
3,212
2,914
3,903
1,643
38,307
38,096
33,554
33,737
32,012
22,019
15,224
9,284
9,511
8,739
3,035
2,579
3,465
4,975
6,056
7,762
10,520
30,218
13,044
14,723
17,745
18,777
14,987
16,622
17,801
14,573
13,190
4,311
4,31113,19014,57317,80116,62214,98718,77717,74514,72313,04430,21810,5207,7626,0564,9753,4652,5793,0358,7399,5119,28415,22422,01932,01233,73733,55438,09638,3071,6433,9032,9143,2127,49710,00711,26211,1149,3059,29013,66412,92916,25952,40283,83897,727110,919131,992170,940187,895206,756214,869250,38837,08037,81338,05841,17843,59845,02146,46647,38139,14815,94613,40516,37016,11716,131201,927190,482000
   > Total Current Liabilities 
0
0
0
5,210
5,167
6,741
7,227
8,950
6,707
8,370
11,731
15,196
13,593
14,087
14,233
13,792
12,256
12,808
13,541
101,160
84,944
96,272
95,799
98,657
93,352
89,064
93,581
78,611
48,195
13,075
9,810
11,349
8,372
8,606
10,636
10,979
9,865
7,497
3,212
2,914
3,903
1,643
37,906
37,756
33,331
33,635
31,994
21,965
15,224
9,284
9,511
8,739
2,900
2,439
3,304
4,801
4,370
6,196
9,077
28,899
11,853
13,664
16,820
17,796
14,181
15,568
17,251
14,165
13,190
4,311
4,31113,19014,16517,25115,56814,18117,79616,82013,66411,85328,8999,0776,1964,3704,8013,3042,4392,9008,7399,5119,28415,22421,96531,99433,63533,33137,75637,9061,6433,9032,9143,2127,4979,86510,97910,6368,6068,37211,3499,81013,07548,19578,61193,58189,06493,35298,65795,79996,27284,944101,16013,54112,80812,25613,79214,23314,08713,59315,19611,7318,3706,7078,9507,2276,7415,1675,210000
       Short-term Debt 
0
0
0
784
617
532
562
593
625
1,030
968
919
1,463
1,381
1,443
1,390
1,385
1,404
1,423
1,442
1,461
1,481
1,723
1,710
1,718
1,912
1,594
1,241
896
870
844
851
858
866
873
853
776
699
478
0
0
0
34,775
33,743
30,936
30,344
29,667
19,403
12,651
5,770
5,488
5,085
5,085
0
0
0
450
0
0
0
0
0
519
663
678
1,814
1,844
1,977
1,909
0
01,9091,9771,8441,814678663519000004500005,0855,0855,4885,77012,65119,40329,66730,34430,93633,74334,7750004786997768538738668588518448708961,2411,5941,9121,7181,7101,7231,4811,4611,4421,4231,4041,3851,3901,4431,3811,4639199681,030625593562532617784000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,743
0
0
0
19,403
12,651
5,770
5,488
5,085
0
0
0
0
450
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000045000005,0855,4885,77012,65119,40300033,7430000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,665
17,538
19,656
11,382
8,932
6,609
8,141
7,514
7,740
9,763
10,126
9,028
6,773
2,734
2,914
3,903
1,643
2,009
2,400
1,737
1,964
1,863
2,238
2,274
2,637
3,475
3,435
2,900
2,429
3,291
4,786
3,920
5,735
8,605
13,416
11,358
12,827
15,537
5,931
2,956
1,834
3,862
6,419
4,706
1,037
1,0374,7066,4193,8621,8342,9565,93115,53712,82711,35813,4168,6055,7353,9204,7863,2912,4292,9003,4353,4752,6372,2742,2381,8631,9641,7372,4002,0091,6433,9032,9142,7346,7739,02810,1269,7637,7407,5148,1416,6098,93211,38219,65617,53813,6650000000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73,487
74,449
57,714
35,917
3,273
2,357
2,357
0
0
0
0
61
25
0
1,776
0
0
446
457
462
1,197
436
324
299
877
548
219
1,463
10
13
15
450
461
472
15,483
495
837
11,293
9,219
9,215
9,882
10,692
5,539
6,575
0
06,5755,53910,6929,8829,2159,21911,29383749515,4834724614501513101,4632195488772993244361,197462457446001,7760256100002,3572,3573,27335,91757,71474,44973,4870000000000000000000000000
   > Long-term Liabilities 
0
0
0
185,272
196,760
9,390
8,890
7,420
6,698
7,576
27,417
32,185
32,873
30,934
29,364
27,386
25,802
25,005
23,539
149,228
129,925
110,484
92,096
72,283
38,640
21,855
4,146
5,227
4,207
3,184
3,119
2,315
918
699
478
283
142
0
0
0
0
0
401
340
223
102
18
54
54
0
0
0
135
140
161
174
1,686
1,566
1,443
1,319
1,191
1,059
925
981
806
1,054
550
408
0
0
004085501,0548069819251,0591,1911,3191,4431,5661,686174161140135000545418102223340401000001422834786999182,3153,1193,1844,2075,2274,14621,85538,64072,28392,096110,484129,925149,22823,53925,00525,80227,38629,36430,93432,87332,18527,4177,5766,6987,4208,8909,390196,760185,272000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,435
2,195
1,986
1,776
1,564
1,351
1,136
918
699
478
283
142
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000001422834786999181,1361,3511,5641,7761,9862,1952,4350000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
729
0
0
401
340
223
102
18
54
0
0
0
0
135
140
161
174
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001741611401350000541810222334040100729000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,420
1,951
3,241
2,431
1,620
1,768
1,179
0
0
0
0
0
0
0
0
0
0
401
340
223
102
18
54
0
0
0
0
135
140
161
174
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001741611401350000541810222334040100000000001,1791,7681,6202,4313,2411,95119,4200000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189,099
182,012
174,288
178,702
196,363
190,570
175,915
169,455
158,181
146,733
134,611
124,101
117,018
112,909
109,085
103,233
99,531
36,206
31,425
27,989
23,482
19,604
16,071
13,836
30,346
24,882
30,774
142,851
136,963
129,951
119,945
105,814
93,111
81,272
68,336
97,519
108,961
94,059
76,069
104,089
85,164
60,736
41,089
27,084
79,062
79,06227,08441,08960,73685,164104,08976,06994,059108,96197,51968,33681,27293,111105,814119,945129,951136,963142,85130,77424,88230,34613,83616,07119,60423,48227,98931,42536,20699,531103,233109,085112,909117,018124,101134,611146,733158,181169,455175,915190,570196,363178,702174,288182,012189,0990000000000000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33
33
33
33
33
34
34
34
34
34
34
34
34
34
34
34
34
11
11
11
12
12
1
2
4
4
6
12
12
12
12
12
12
12
12
17
22
22
22
31
31
31
31
31
31
31313131313122222217121212121212121264421121211111134343434343434343434343433333333330000000000000000000000000
   Retained Earnings Total Equity0000-357,127-337,199-314,761-295,854-279,821-262,573-258,520-244,910-232,204-218,425-203,342-192,505-184,811-178,329-173,494-167,741-161,948-152,120-147,982-144,232-139,461-134,629-131,037-125,907-324,344-320,008-313,256-308,628-303,768-295,632-280,633-267,267-254,365-241,994-233,928-218,058-210,179-224,671-226,930-217,125-208,0710000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-4,872
-4,872
-4,872
-4,872
-5,652
-5,652
-5,652
-5,652
-6,515
-6,515
-6,515
-6,515
-8,232
-8,232
0
0
-10,049
-10,049
0
0
-11,876
-11,876
0
0
-12,832
-12,832
0
0
-3,869
-3,869
0
0
-1,878
-1,878
0
0
-1,671
-1,671
0
0
-5,701
-5,701
0
0
-1,860
-1,860
0
0
-2,023
-2,023
0
0
-285
-285
0
0
-400
0
0
8
5
5
2
1
0
0
0
0001255800-40000-285-28500-2,023-2,02300-1,860-1,86000-5,701-5,70100-1,671-1,67100-1,878-1,87800-3,869-3,86900-12,832-12,83200-11,876-11,87600-10,049-10,04900-8,232-8,232-6,515-6,515-6,515-6,515-5,652-5,652-5,652-5,652-4,872-4,872-4,872-4,872000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
396,938
399,123
401,149
403,113
406,315
408,217
409,608
411,227
412,526
413,871
415,123
419,633
420,642
421,448
422,303
423,184
423,830
162,086
162,450
162,603
162,924
163,820
164,053
165,954
192,290
192,615
204,262
321,172
321,758
322,468
323,279
324,214
325,246
326,139
326,810
359,935
388,719
389,883
390,803
441,252
442,258
0
0
0
0
0000442,258441,252390,803389,883388,719359,935326,810326,139325,246324,214323,279322,468321,758321,172204,262192,615192,290165,954164,053163,820162,924162,603162,450162,086423,830423,184422,303421,448420,642419,633415,123413,871412,526411,227409,608408,217406,315403,113401,149399,123396,9380000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
199
-19
36
227
194
377
201
188
-14
95
87
66
110
55
4
23
11
16
1
4
7
4
-1
0
0
4
0
-4
4
-24
-4
13
57
31
34
140
41
389,883
390,803
441,252
442,258
443,069
443,752
444,283
0
0444,283443,752443,069442,258441,252390,803389,8834114034315713-4-244-40400-14741161123455110668795-1418820137719422736-191990000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.